| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $117.0M | +79.4% |
| R&D Expense | $8.1M | -16.4% |
| SG&A Expense | $33.7M | +61.7% |
| Operating Income | -$37.9M | -28.9% |
| Pre-tax Income | -$43.7M | -3.7% |
| Income Tax | $183K | +153.0% |
| Net Income | -$43.9M | -5.0% |
| EPS (Basic) | -$0.56 | +8.2% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | -30.8% |
| Accounts Receivable | $13.7M | +29.5% |
| Inventory | $2.6M | +1.2% |
| Current Assets | $31.3M | -11.2% |
| Total Assets | $76.8M | -10.4% |
| Current Liabilities | $60.1M | +18.0% |
| Long-term Debt | $28.1M | — |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | +4.0% |
| Capital Expenditures | $3.7M | +16.7% |
| Investing Cash Flow | -$4.0M | -403.0% |
| Financing Cash Flow | $7.5M | -55.0% |
| Free Cash Flow | -$12.9M | -1.2% |
| Total Liabilities |
| $87.7M |
| +13.0% |
| Stockholders' Equity | -$10.9M | -234.2% |